Literature DB >> 28680311

Psychiatric Comorbidity, Sexual Dysfunction, and Quality of Life in Patients Undergoing Hemodialysis: A Case-Control Study.

Özlem Devrim Balaban1, Erkan Aydin1, Ali Keyvan1, Menekşe Sıla Yazar1, Özgecan Tuna2, Halise Devrimci Özgüven3.   

Abstract

INTRODUCTION: Due to disabilities caused by the disease and the requirement of dialysis, end-stage renal disease (ESRD) is frequently comorbid with psychiatric disorders, adversely affects quality of life, and causes significant sexual dysfunction (SD). We aimed to investigate the psychiatric comorbidity, quality of life, depression and anxiety levels, and SD in ESRD patients undergoing hemodialysis.
METHODS: Forty-nine patients undergoing hemodialysis treatment in a dialysis center and 44 non-ESRD control subjects selected with snowball sampling were enrolled in the study. All subjects were assessed using Structured Clinical Interview for Axis-I Disorders (SCID-I). Sociodemographic data form, Hospital Anxiety and Depression Scale (HADS), Arizona Sexual Experience Scale (ASEX), and World Health Organization Quality of Life Short Form Turkish Version Scale (WHOQOL-BREF-TR) were applied to both groups.
RESULTS: There was no difference between the groups in terms of sex, age, education period, marital status, presence of additional physical illness, and past history of psychiatric disorders. Compared with the control group, HADS depression subscale and ASEX scores were significantly high (p<0.01) in the patient group, and WHOQOL-BREF-TR psychological and physical domain scores were low (p<0.05 and p<0.01, respectively). There was a significant negative relationship between HADS scores and WHOQOL-BREF-TR psychological, environmental, and national environmental scores in the patient group (p<0.05). When the differences between the groups were re-analyzed after controlling HADS depression scores with covariance analysis, the significant difference in ASEX and WHOQOL-BREF-TR physical domain scores between the groups remained, but the significant difference in WHOQOL-BREF-TR psychological domain scores disappeared.
CONCLUSION: The quality of life of ESRD patients was lower, especially in the psychological and physical domains, and psychiatric comorbidities and SD rates were higher than in non-ESRD control subjects. Quality of life is affected by SD. Recognizing and treating depressive symptoms will help improve the quality of life, especially in the psychological domain.

Entities:  

Keywords:  Kidney failure; comorbidity; quality of life; sexual dysfunctions

Year:  2017        PMID: 28680311      PMCID: PMC5491663          DOI: 10.5152/npa.2016.12677

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  34 in total

1.  Poor quality of life is associated with increased mortality in maintenance hemodialysis patients: a prospective cohort study.

Authors:  Ibrahim Guney; Huseyin Atalay; Yalcin Solak; Lutfullah Altintepe; H Zeki Tonbul; Suleyman Turk
Journal:  Saudi J Kidney Dis Transpl       Date:  2012-05

2.  Quality-of-life impairment in depressive and anxiety disorders.

Authors:  Mark Hyman Rapaport; Cathryn Clary; Rana Fayyad; Jean Endicott
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

3.  Do sexual dysfunctions get better during dialysis? Results of a six-month prospective follow-up study from Turkey.

Authors:  A Soykan; H Boztas; S Kutlay; E Ince; G Nergizoglu; A Y Dileköz; O Berksun
Journal:  Int J Impot Res       Date:  2005 Jul-Aug       Impact factor: 2.896

4.  Diagnosis of depression in patients with end-stage renal disease. Comparative analysis.

Authors:  M D Smith; B A Hong; A M Robson
Journal:  Am J Med       Date:  1985-08       Impact factor: 4.965

5.  The diagnosis of major depression in renal dialysis patients.

Authors:  J L Craven; G M Rodin; L Johnson; S H Kennedy
Journal:  Psychosom Med       Date:  1987 Sep-Oct       Impact factor: 4.312

6.  Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients.

Authors:  Edmund G Lowrie; Roberta Braun Curtin; Nancy LePain; Dorian Schatell
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

7.  Quality of life in male hemodialysis patients. Role of erectile dysfunction.

Authors:  Süleyman Türk; Ibrahim Guney; Lutfullah Altintepe; Zeki Tonbul; Alaattin Yildiz; Mehdi Yeksan
Journal:  Nephron Clin Pract       Date:  2004

8.  Sexual function and quality of life in Korean women with chronic renal failure on hemodialysis: case-control study.

Authors:  Yun Seob Song; Hee Jo Yang; Eun Seop Song; Dong Cheol Han; Chul Moon; Ja Hyeon Ku
Journal:  Urology       Date:  2008-02       Impact factor: 2.649

9.  Erectile dysfunction in chronic renal failure patients undergoing hemodialysis in Egypt.

Authors:  M-E M Ali; H Z Abdel-Hafez; A M Mahran; H Z Mohamed; E R Mohamed; A M El-Shazly; A M Gadallah; M A Abbas
Journal:  Int J Impot Res       Date:  2005 Mar-Apr       Impact factor: 2.896

Review 10.  Sexual dysfunction and depression: etiology, prevalence, and treatment.

Authors:  R Shabsigh; L Zakaria; A G Anastasiadis; A S Seidman
Journal:  Curr Urol Rep       Date:  2001-12       Impact factor: 2.862

View more
  3 in total

Review 1.  A holistic approach to factors affecting depression in haemodialysis patients.

Authors:  Georgia Gerogianni; Anastasios Kouzoupis; Eirini Grapsa
Journal:  Int Urol Nephrol       Date:  2018-05-19       Impact factor: 2.370

2.  Resilience: A Protective Factor from Depression and Anxiety in Mexican Dialysis Patients.

Authors:  Cristina J González-Flores; Guillermo García-García; Abel Lerma; Héctor Pérez-Grovas; Rosa M Meda-Lara; Rebeca M E Guzmán-Saldaña; Claudia Lerma
Journal:  Int J Environ Res Public Health       Date:  2021-11-14       Impact factor: 3.390

3.  Effectiveness of exercise on fatigue in hemodialysis patients: a randomized controlled trial.

Authors:  Farzaneh Salehi; Mahlagha Dehghan; Parvin Mangolian Shahrbabaki; Mohammad Reza Ebadzadeh
Journal:  BMC Sports Sci Med Rehabil       Date:  2020-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.